Discover the full record of transactions filed by Gault Cheryl. Director active across 1 company, notably Rapport Therapeutics, Inc.. Cumulatively, 8 disclosures have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €589k. History available since 3 March 2025. The latest transaction was disclosed on 30 September 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Gault Cheryl is a declarant with 6 filings in total. In the sampled recent filings between 2025-03-05 and 2026-03-31, sales total EUR 296023 and the modal transaction nature is sale, mainly related to Rapport Therapeutics, Inc., where she is Chief Operating Officer.